Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometrySON, Junghyun; LEE, Jaeick; LEE, Mijin et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 3, pp 657-661, issn 0731-7085, 5 p.Article

Oxiracetam pre- but not post-treatment prevented social recognition deficits produced with trimethyltin in ratsHLINAK, Zdenek; KREJCI, Ivan.Behavioural brain research. 2005, Vol 161, Num 2, pp 213-219, issn 0166-4328, 7 p.Article

Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in miceHLINAK, Zdenek; KREJCI, Ivan.Behavioural brain research. 2002, Vol 133, Num 2, pp 395-399, issn 0166-4328Article

Determination of oxiracetam in human serum and urine by high-performance liquid chromatographyVISCONTI, M; SPALLUTO, R; CROLLA, T et al.Journal of chromatography. 1987, Vol 416, Num 2, pp 433-438, issn 0021-9673Article

Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteersPERUCCA, E; ALBRICI, A; GATTI, G et al.European journal of drug metabolism and pharmacokinetics. 1984, Vol 9, Num 3, pp 267-274, issn 0378-7966Article

Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosaMANCINI, A; VALLE, D; CONTE, G et al.Psychoneuroendocrinology. 1996, Vol 21, Num 7, pp 621-629, issn 0306-4530Article

Direct chromatographic separation of the enantiomers of oxiracetamCAMILLERI, P; MURPHY, J. A; THORPE, C et al.Journal of chromatography. 1990, Vol 508, Num 1, pp 208-211, issn 0021-9673, 4 p.Article

Papers/Drugs affective cognitive disorders: a symposium. A session of the Collegium Internationale Neuro-Psychopharmacologicum. 14th meeting, Florence June 23, 1984Clinical neuropharmacology. 1986, Vol 9, issn 0362-5664, 84 p., suppl. 3Conference Proceedings

Facilitating effect of oxiracetam and piracetam on acquisition of discrete two-way shuttle avoidance in normal miceKURIBARA, H; TADOKORO, S.Japanese journal of pharmacology. 1988, Vol 48, Num 4, pp 494-498, issn 0021-5198Article

Effects of oxiracetam on electroencephalogram at rest in healthy young subjects: single- and repeated-dose investigationGUAZZELLI, M; ROCCA, R; LATTANZI, L et al.Current therapeutic research. 1987, Vol 41, Num 2, pp 234-243, issn 0011-393XArticle

Improvement of avoidance acquisition by the nootropic drug oxiracetam in miceSANSONE, M; CASTELLANO, E; AMMASSARI-TEULE, M et al.Archives internationales de pharmacodynamie et de thérapie. 1985, Vol 275, Num 1, pp 86-92, issn 0003-9780Article

Solid-state structure and conformation of the nootropic agent 4-hydroxy-2-oxo-1-pyrrolidineacetamide: X-ray and theoretical self-consistant field molecular orbital (SCF-MO) studiesBANDOLI, G; GRASSI, A; NICOLINI, M et al.Chemical and pharmaceutical bulletin. 1985, Vol 33, Num 10, pp 4395-4401, issn 0009-2363Article

Determination of oxiracetam in plasma and urine by column-switching high-performance liquid chromatographyLECAILLON, J. B; SOUPPART, C; LE DUIGOU, F et al.Journal of chromatography. 1989, Vol 497, pp 223-230, issn 0021-9673Article

Effect of oxiracetam on cerebral cholinergic imbalance secondary to an NMDA-receptor blockadePONZIO, F; BELFIORE, P; DORIGOTTI, L et al.Pharmacological research. 1989, Vol 21, pp 103-104, issn 1043-6618, suppl. 1Conference Paper

Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementiaVILLARDITA, C; PARINI, J; GRIOLI, S et al.Journal of neural transmission. Supplementum. 1987, Num 24, pp 293-298, issn 0303-6995Conference Paper

Controlled clinical trial of oxiracetam in the treatment of chronic cerebrovascular insufficiency in the elderlyFERRERO, E.Current therapeutic research. 1984, Vol 36, Num 2, pp 298-308, issn 0011-393XArticle

Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial mazeMAGNANI, M; POZZI, O; BIAGETTI, R et al.Psychopharmacologia. 1992, Vol 106, Num 2, pp 175-178, issn 0033-3158Article

Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomesRAITERI, M; COSTA, R; MARCHI, M et al.Neuroscience letters. 1992, Vol 145, Num 1, pp 109-113, issn 0304-3940Article

Effect of oxiracetam on cerebrosvascular impairment in ratsKOMETANI, M; OKADA, M; TAKEMORI, E et al.Arzneimittel-Forschung. 1991, Vol 41, Num 7, pp 684-689, issn 0004-4172Article

A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholineGRAZIA GIOVANNINI, M; SPIGNOLI, G; CARLA, V et al.Pharmacological research. 1991, Vol 24, Num 4, pp 395-405, issn 1043-6618Article

Pharmacokinetics of oxiracetam in patients with renal impairement after a 800 mg single oral doseLECAILLON, J. B; DUBOIS, J. P; COPPENS, H et al.European journal of drug metabolism and pharmacokinetics. 1990, Vol 15, Num 3, pp 231-237, issn 0378-7966, 7 p.Article

The effect of oxiracetam treatment on alterations of lipid metabolism in brain areas from spontaneously hypertensive ratsPERINI, S; BRUNETTI, M; PARNETTI, L et al.Pharmacological research. 1989, Vol 21, Num 3, pp 313-323, issn 1043-6618Article

Organic brain syndrome treated with oxiracetam: a double-blind randomized controlled trialHJORTHER, A; BROWNE, E; JAKOBSEN, K et al.Acta neurologica scandinavica. 1987, Vol 75, Num 4, pp 271-276, issn 0001-6314Article

The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged miceDE ANGELIS, L; FURLAN, C.Neurobiology of learning and memory (Print). 1995, Vol 64, Num 2, pp 119-124, issn 1074-7427Article

Page / 3